000			01798 a2200505 4500
005			20250518013025.0
264		0	_c20200907
008			202009s 0 0 eng d
022			_a1463-1326
024	7		_a10.1111/dom.13609 _2doi
040			_aNLM _beng _cNLM
100	1		_aKuhadiya, Nitesh D
245	0	0	_aAddition of glucagon-like peptide-1 receptor agonist therapy to insulin in C-peptide-positive patients with type 1 diabetes. _h[electronic resource]
260			_bDiabetes, obesity & metabolism _c04 2019
300			_a1054-1057 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdult
650	0	4	_aAutoantibodies _ximmunology
650	0	4	_aBody Weight
650	0	4	_aC-Peptide _xmetabolism
650	0	4	_aDeprescriptions
650	0	4	_aDiabetes Mellitus, Type 1 _xdrug therapy
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aGlucagon-Like Peptides _xanalogs & derivatives
650	0	4	_aGlutamate Decarboxylase _ximmunology
650	0	4	_aGlycated Hemoglobin _xmetabolism
650	0	4	_aHumans
650	0	4	_aHypoglycemic Agents _xtherapeutic use
650	0	4	_aImmunoglobulin Fc Fragments _xtherapeutic use
650	0	4	_aInsulin _xtherapeutic use
650	0	4	_aLiraglutide _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aRecombinant Fusion Proteins _xtherapeutic use
650	0	4	_aRetrospective Studies
650	0	4	_aTreatment Outcome
650	0	4	_aWeight Loss
650	0	4	_aGlucagon-Like Peptide-1 Receptor Agonists
700	1		_aProhaska, Ben
700	1		_aGhanim, Husam
700	1		_aDandona, Paresh
773	0		_tDiabetes, obesity & metabolism _gvol. 21 _gno. 4 _gp. 1054-1057
856	4	0	_uhttps://doi.org/10.1111/dom.13609 _zAvailable from publisher's website
999			_c29149971 _d29149971